RT Journal Article
SR Electronic
T1 A Saudi G6PD Deficient Girl Died with Pediatric Multisystem Inflammatory Syndrome-COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.08.20137497
DO 10.1101/2020.07.08.20137497
A1 Al-Aamri, Maryam A.
A1 Al-Khars, Fatimah T.
A1 Alkhwaitem, Sami J.
A1 AlHassan, Abdulaziz K.
A1 Aithan, Ali M. Al
A1 Alkhalifa, Fatima H.
A1 Al-Abdi, Sameer Y.
YR 2020
UL http://medrxiv.org/content/early/2020/07/11/2020.07.08.20137497.abstract
AB Reports on pediatric multisystem inflammatory syndrome (PMIS) temporally related to coronavirus disease 2019 (COVID-19) are increasing. African and Afro-Caribbean children constituted about 37% of the cases in these reports. Although glucose-6-phosphatase dehydrogenase (G6PD) deficiency is common among this population, the G6PD status of these cases has not been reported. We report the first case of PMIS related to COVID-19 from Saudi Arabia. This case was a Saudi G6PD deficient girl who died with PMIS related to COVID-19. G6PD deficiency induces redox imbalance and exaggerates the inflammatory response; thus, it might contribute to the development or the grave outcome of our case. We urgently need to assess the association between G6PD deficiency and COVID-19 in a large study as the G6PD deficiency may be a useful predictor for the progression of the COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAll authors have no example conflicts of interest to disclose.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The IRB of Maternal and children hospital waived the consent.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data are available upon request.